Showing results (351-360 of 401) with videos related to

Sort By:
Pageof 41
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2011
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PETBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.
Cell Death and Differentiation|July 13, 2000
Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cellsT Gotow, M Shibata, S Kanamori, et al.
Cancer|January 8, 2005
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survivalLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Clinical Breast Cancer|November 28, 2017
Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast CancerAmy E Chang, Qian V Wu, Isaac C Jenkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2016
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast CancerBrenda F Kurland, Lanell M Peterson, Jean H Lee, et al.
Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Chemical Science|June 17, 2026
Lipids and lipid nanoparticles functionalized with randomized poly(ethylene glycol) (rPEG) for mRNA deliveryPhilip Dreier, Caroline Bockhard, David Seibel, et al.
Oncology Reports|May 21, 2011
P53 gene alterations in differentiated thyroid cancersM Herrmann, D Baunoch, M Maliarik, et al.
Annals of Internal Medicine|April 1, 1979
Nosocomial Legionnaires' disease in Columbus, OhioJ S Marks, T F Tsai, W J Martone, et al.
Clinical Breast Cancer|May 31, 2015
Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is NewEunpi Cho, Ann K Schwemm, Lena M Rubinstein, et al.
Pageof 41